HBsAg levels prediction of effects of pegylated interferon α-2a combined with adefovir dipivoxil in treating patients with HBeAg positive chronic hepatitis B

YANG Li; FU Wan-zhi

doi:10.3969/j.issn.1671-6450.2013.05.007

Home>Articles>HBsAg levels prediction of effects of pegylated interferon α-2a combined with adefovir dipivoxil in treating patients with HBeAg positive chronic hepatitis B

DOI: 10.3969/j.issn.1671-6450.2013.05.007

HBsAg levels prediction of effects of pegylated interferon α-2a combined with adefovir dipivoxil in treating patients with HBeAg positive chronic hepatitis B

YANG Li

FU Wan-zhi

Machine-generated Keywords：

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 346-348 )

CHINESE JOURNAL OF DIFFICULT AND COMPLICATED CASES

ISTIC

ISSN：1671-6450

Year, Vol.(Issue)：2013,12(5)